Literature DB >> 14713716

Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis.

Tanuja Chitnis1, Samia J Khoury.   

Abstract

Cytokines play an important role in the pathogenesis of both multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Effective treatments for both diseases have been shown to alter cytokines in the central nervous system and in activated mononuclear cells. EAE is an animal model that mimics many aspects of multiple sclerosis, and has been widely used to study the mechanisms of disease and therapeutic approaches to multiple sclerosis. Cytokines play an important role in regulation of disease expression in EAE, and in tolerance to disease induction. In this review, we will summarize the current findings on the role of cytokine shifts in the induction of tolerance in EAE. In addition, we will discuss modulation of EAE by altered expression of members of the cytokineregulated Jak/STAT intracellular signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14713716     DOI: 10.1385/IR:28:3:223

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  121 in total

1.  IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions.

Authors:  Arnon Karni; Djordje N Koldzic; Padmanabhan Bharanidharan; Samia J Khoury; Howard L Weiner
Journal:  J Neuroimmunol       Date:  2002-04       Impact factor: 3.478

2.  A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice.

Authors:  M Falcone; A J Rajan; B R Bloom; C F Brosnan
Journal:  J Immunol       Date:  1998-05-15       Impact factor: 5.422

3.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

Authors:  K E Balashov; D R Smith; S J Khoury; D A Hafler; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.

Authors:  H Körner; F A Lemckert; G Chaudhri; S Etteldorf; J D Sedgwick
Journal:  Eur J Immunol       Date:  1997-08       Impact factor: 5.532

5.  Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.

Authors:  L D Johns; K C Flanders; G E Ranges; S Sriram
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

6.  The role of IFN-gamma in the production of Th2 subpopulations: implications for variable Th2-mediated pathologies in autoimmunity.

Authors:  A Wensky; M C Marcondes; J J Lafaille
Journal:  J Immunol       Date:  2001-09-15       Impact factor: 5.422

Review 7.  Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis.

Authors:  Suhayl Dhib-Jalbut
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

8.  Human tumor necrosis factor-alpha augments experimental allergic encephalomyelitis in rats.

Authors:  Y Kuroda; Y Shimamoto
Journal:  J Neuroimmunol       Date:  1991-11       Impact factor: 3.478

9.  Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats.

Authors:  E Cash; A Minty; P Ferrara; D Caput; D Fradelizi; O Rott
Journal:  J Immunol       Date:  1994-11-01       Impact factor: 5.422

10.  IL-12 unmasks latent autoimmune disease in resistant mice.

Authors:  B M Segal; E M Shevach
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

View more
  11 in total

1.  T-bet is essential for the progression of experimental autoimmune encephalomyelitis.

Authors:  Narender Nath; Ratna Prasad; Shailendra Giri; Avtar K Singh; Inderjit Singh
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

2.  Heparanase upregulates Th2 cytokines, ameliorating experimental autoimmune encephalitis.

Authors:  Menachem Bitan; Lola Weiss; Israel Reibstein; Michael Zeira; Yakov Fellig; Shimon Slavin; Eyal Zcharia; Arnon Nagler; Israel Vlodavsky
Journal:  Mol Immunol       Date:  2010-06       Impact factor: 4.407

3.  Bifunctional Peptide Inhibitors Suppress Interleukin-6 Proliferation and Ameliorates Murine Collagen-Induced Arthritis.

Authors:  Barlas Büyüktimkin; Paul Kiptoo; Teruna J Siahaan
Journal:  J Clin Cell Immunol       Date:  2014-12

4.  S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.

Authors:  Narender Nath; Osamu Morinaga; Inderjit Singh
Journal:  J Neuroimmune Pharmacol       Date:  2010-01-21       Impact factor: 4.147

5.  Both positive and negative effects on immune responses by expression of a second class II MHC molecule.

Authors:  Peggy P Ni; Yaming Wang; Paul M Allen
Journal:  Mol Immunol       Date:  2014-07-10       Impact factor: 4.407

Review 6.  Therapeutic targeting of STAT pathways in CNS autoimmune diseases.

Authors:  Charles E Egwuagu; Joseph Larkin Iii
Journal:  JAKSTAT       Date:  2013-01-01

Review 7.  Potential immunological consequences of pharmacological suppression of gastric acid production in patients with multiple sclerosis.

Authors:  Sangita Biswas; Stephen H Benedict; Sharon G Lynch; Steven M LeVine
Journal:  BMC Med       Date:  2012-06-07       Impact factor: 8.775

8.  Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.

Authors:  Yun Hou; Chung Heon Ryu; Kwang Ywel Park; Seong Muk Kim; Chang Hyun Jeong; Sin-Soo Jeun
Journal:  Stem Cell Res Ther       Date:  2013-07-05       Impact factor: 6.832

9.  Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.

Authors:  Beatriz Bravo; Marta I Gallego; Ana I Flores; Rafael Bornstein; Alba Puente-Bedia; Javier Hernández; Paz de la Torre; Elena García-Zaragoza; Raquel Perez-Tavarez; Jesús Grande; Alicia Ballester; Sara Ballester
Journal:  Stem Cell Res Ther       Date:  2016-03-17       Impact factor: 6.832

10.  Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAE.

Authors:  RuiRong Yuan; Yasuhiro Maeda; Weiping Li; Wei Lu; Stuart Cook; Peter Dowling
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.